How do I buy Prelude Therapeutics (PRLD) stock?

You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.View our list of the best stock brokerages

Who are Prelude Therapeutics (PRLD) competitors?

Other companies in Prelude Therapeutics’s space includes: Macrogenics Inc (NASDAQ:MGNX), Fortress Biotech Inc (NASDAQ:FBIO), Tharimmune Inc (NASDAQ:THAR), Anixa Biosciences Inc (NASDAQ:ANIX) and Connect Biopharma Holdings Ltd (NASDAQ:CNTB).

What is the forecast, or price target, for Prelude Therapeutics (PRLD) stock?

Prelude Therapeutics has a consensus price target of $4.17.

What is the current price for Prelude Therapeutics (PRLD)?

The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $1.83 last updated January 20, 2026 at 4:28 AM EST.

Does Prelude Therapeutics (PRLD) pay a dividend?

There are no upcoming dividends for Prelude Therapeutics.

When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?

Prelude Therapeutics does not have any upcoming earnings scheduled.

Is Prelude Therapeutics (PRLD) going to split?

There is no upcoming split for Prelude Therapeutics.

What sector and industry does Prelude Therapeutics (PRLD) operate in?

Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prelude Therapeutics (PRLD) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

Comments